CANBUD has established a footprint in Jamaica where psychedelics is already permissible and shroom tourism will be in demand. CANBUD is at the forefront of psilocybin micro-dosing development, and in the process of discussing an off-take agreement to supply psilocybin extract for R&D purposes. On the functional mushroom front, CANBUD is developing mushroom based immune and nootropic cognitive enhancement products. CANBUD positions itself to be a leader in early movers within this industry.
